Approaches to the treatment of bullous pemphigoid
DOI:
https://doi.org/10.33448/rsd-v11i17.38924Keywords:
Bullous pemphigoid; Therapeutics; Dermatology.Abstract
Bullous pemphigoid is a rare disease evidenced by a generalized vesiculobullous eruption that most commonly affects the elderly and children. Given the above, the study aims to analyze the treatments for bullous pemphigoid. This is an integrative literature review carried out using the Scientific Electronic Library Online (SciELO), Latin American and Caribbean Literature in Health Sciences (LILACS) and Medical Literature Analysis and Retrieval System Online (MEDLINE) databases. of the following Descriptors in Health Sciences (DeCS): "bullous pemphigoid" and "therapeutic". Combined with each other by the Boolean operator AND. As inclusion criteria: articles available in full, in Portuguese, Spanish and English, that addressed the theme , in the last ten years (2012-2022). As exclusion criteria: articles that did not contemplate the theme and repeated studies in the databases. 57 articles were found, after the combined search of descriptors and Boolean operators, 5 articles were selected to compose the final sample.Therapeutic should be chosen based on the degree of disease, type of disease, patient age group and associated comorbidities.
References
Arakawa, M., Ohata, C., Tsuruta, D., Ishii, N., Sogame, R., Nakama, T., ... & Hashimoto, T. (2016). A severe and prolonged case of pemphigoid gestationis successfully treated with combination therapies. The British journal of dermatology, 174(4), 925-927.
Chang, B., Tholpady, A., Huang, R. S., Nedelcu, E., & Bai, Y. (2014). Clinical and serological responses following plasmapheresis in bullous pemphigoid: two case reports and a review of the literature. Blood Transfusion, 12(2), 269.
Cui, Y., Hu, C., Cheng, Y., Han, X., & Wang, W. (2022). Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2. International Journal of Dermatology, 61(2), 252-256.
Ercole, F. F., Melo, L. S. D., & Alcoforado, C. L. G. C. (2014). Revisão integrativa versus revisão sistemática. Revista Mineira de Enfermagem, 18(1), 9-12.
Hattori, Y., Takahashi, T., & Seishima, M. (2017). Bullous pemphigoid successfully treated with a combination therapy of plasmapheresis followed by intravenous high dose immunoglobulin. Therapeutic Apheresis and Dialysis, 21(4), 421-423.
Kridin, K., Ahn, C., Huang, W. C., Ansari, A., & Sami, N. (2019). Treatment update of autoimmune blistering diseases. Dermatologic Clinics, 37(2), 215-228.
Milnik, A., Roggenbuck, D., Conrad, K., & Bartels, C. (2013). Acute inflammatory neuropathy with monoclonal anti-GM2 IgM antibodies, IgM-κ paraprotein and additional autoimmune processes in association with a diffuse large B-cell non-Hodgkin's lymphoma. Case Reports, 2013, bcr1120115087.
Ohata, C., Fukuda, S., Ishii, N., Koga, H., Hamada, T., Furumura, M., & Hashimoto, T. (2013). Refractory anti-laminin γ1 pemphigoid with psoriasis vulgaris successfully treated by double-filtration plasmapheresis. European Journal of Dermatology, 23(5), 715-716.
Ruocco, E., Wolf, R., Caccavale, S., Brancaccio, G., Ruocco, V., & Schiavo, A. L. (2013). RETRACTED: Bullous pemphigoid: Associations and management guidelines: Facts and controversies. Clinics in dermatology, 31(4), 400-412.
Yoshida, T., Minakuchi, H., Takahashi, R., Morita, S., & Oya, M. (2020). Safety and efficacy of plasma exchange via direct femoral vein puncture in autoimmune blistering diseases. Journal of Clinical Apheresis, 35(3), 172-177.
Zhang, Y., Zhang, J., Chen, J., Xu, Q., Zou, Y., & Chao, J. (2021). Efficacy and safety of dupilumab in moderate-to-severe bullous pemphigoid. Frontiers in immunology, 4144.
da Silveira, S. J. S., Júnior, E. A. F., da Costa Júnior, J. A., de Góis, G. O., & Camera, L. T. B. (2020). Abordagem diagnóstica e terapêutica de penfigoide bolhoso: uma revisão de literatura. Brazilian Journal of Development, 6(12), 95234-95249.
Lonchiati, D. F., de Oliveira, B. S., Silva, A. L. F., Souza, B. S., Carapeba, M. D. O. L., Pivaro, L. R., & Kerche, L. E. (2020, June). Penfigóide bolhoso induzido por fármaco: um relato de caso. In Colloquium Vitae. ISSN: 1984-6436 (Vol. 12, No. 2, pp. 6-11).
dos Santos, A. C. M. (2020). Dificuldade na condução do penfigoide bolhoso no idoso. BWS Journal, 3, 1-7.
Martins, I. C., & Bisol, A. H. (2020). Pênfigo bolhoso em lactente. Perspectivas Experimentais e Clínicas, Inovações Biomédicas e Educação em Saúde (PECIBES) ISSN-2594-9888, 6(2), 30-32.
de Godoy, L. S., Santos, G. M. D., da Cunha Braga, G. A., & Sousa, H. C. Penfigoide bolhoso no lactente e seu principal diagnóstico diferencial: dermatose bolhosa por IgA linear.
Dahan, C. M., da Silva Souza, L. G., de Oliveira, L. D., dos Santos Cividanes, L., Pereira, A. K. G., Kitakawa, D., ... & de Carvalho, S. (2021). A importância do reconhecimento precoce do pênfigo vulgar e tratamento adequado: relato de caso. Revista de Odontologia da Braz Cubas, 11(1), 38-45.
de Lima Melo, M. R., Egypto, L., & Nunes, M. (2021). Penfigóide Bolhoso Paraneoplásico: Relato de Caso/Paraneoplastic Bullous Pemphigoid: Case Report. ID on line. Revista de psicologia, 15(54), 333-340.
de Lima, C. T., Costa, M. K., de Araújo, F. M., Pugliesi, Y., Prado, L., Tavares, S., & Guedes, V. R. (2019). Penfigóide bolhoso, desafio terapêutico em paciente com múltiplas comorbidades. Revista de Patologia do Tocantins, 6(1), 44-46.
Santino, M. F. F., Fernandes, N. C., Quintella, D. C., & Cuzzi, T. (2021). Perturbação Factícia Bolhosa Simulando Penfigoide Bolhoso: Relato de Caso e Revisão da Literatura. Journal of the Portuguese Society of Dermatology and Venereology, 79(2), 163-167.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Rodrigo Daniel Zanoni ; Vitoria Vilas Boas da Silva Bomfim ; Zenaide Paulo Silveira ; Onilda Rubin; André Luiz Faleiro Soares
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
